BioCatalystWatch
PDSBWorkspace / PDSB / OverviewCompany library
PDS Biotechnology Corp logo

PDS Biotechnology Corp

PDS Biotechnology Corp (PDSB)

Website

Price
Market cap
Next catalystOct 1, 2026 - Mar 31, 2027PDS0301 + enzalutamide — biochemically recurrent prostate cancer · Data readoutSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

PDS0301

PreINDP1P2P3FilingApproved
Upcoming / outlook

PDS0301

PreINDP1P2P3FilingApproved
Upcoming / outlook

PDS0301PDS0301 + enzalutamide — biochemically recurrent prostate cancer

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PDS0301

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PDS0301PDS0301 + enzalutamide — biochemically recurrent prostate cancer

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PDS0301

PreINDP1P2P3FilingApproved
Upcoming / outlook

PDS0301

PreINDP1P2P3FilingApproved
Upcoming / outlook

PDS0301

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

PDS0301

PreINDP1P2P3FilingApproved
PDS0301

PreINDP1P2P3FilingApproved
PDS0301

PreINDP1P2P3FilingApproved
PDS0103

MUC1

PreINDP1P2P3FilingApproved
PDS0103

MUC1

PDS0101/PDS0301

PreINDP1P2P3FilingApproved
PDS0101/PDS0301

PreINDP1P2P3FilingApproved
PDS0202

COBRA influenza antigens

PreINDP1P2P3FilingApproved
Infectimune®

COBRA influenza antigens

PreINDP1P2P3FilingApproved

History / paused

TARP

PreINDP1P2P3FilingApproved

HPV16 E6 × HPV16 E7

PreINDP1P2P3FilingApproved
PDS0301

PreINDP1P2P3FilingApproved

HPV16 E6 × HPV16 E7

PreINDP1P2P3FilingApproved

HPV16 E6 × HPV16 E7

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

SARS-CoV-2 protein antigen

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PDSB PR & News

PDSB SEC archive